Investor Presentaiton slide image

Investor Presentaiton

Vision: The First 900kDa Neurotoxin with an "Extra Strength" Dose Building on the Strength of the "Original" Formulation "Original" "Extra Strength" prabotulinumtoxinA-xvfs Jeuveau for action 100 UNITS VIAL For Intramuscular Use 1 Single-Dose Vial X Designed by Evalu prabotulinumtoxinA-xvfs jeuveau for ction 100 UNITS VIAL For Intramuscular Use 1 Single-Dose Vial X Designed by Eval JeuveauⓇ 20U Dose / 0.5mL Concentration Jeuveau 40U Dose / 0.25mL Concentration Pipeline in a Product This program is designed to offer consumers an "extra strength" dosing option Evolus is uniquely positioned to capitalize on this opportunity with the company's aesthetics- only strategy and Jeuveau product precision Ⓡ в 8 15
View entire presentation